Stocks
Pfizer (PFE) EBITDA margin US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| EBITDA margin, % | ? | 36.4% | 31.4% | 37.9% | 40.9% | 16.3% | 36.0% | ||
| Changes by years, y/y, % | -3pp | -5pp | +6pp | +3pp | -25pp | -16.4% | |||
Pfizer. EBITDA margin, %
Pfizer. EBITDA margin, changes, pp
Pfizer (PFE) EBITDA margin US GAAP (quarter values) |
||||||||
| 2023Q4 | 2024Q1 | 2024Q1 | 2024Q2 | 2024Q3 | LTM ? | |||
| EBITDA margin, % | ? | -12.4% | 42.0% | 40.0% | 18.1% | 41.0% | 36.0% | |
| Changes by years, y/y, % | -44pp | -1pp | -3pp | -11pp | +49pp | |||
| Changes by quarters, q/q, % | -4pp | +54pp | -2pp | -22pp | +23pp | |||
